Brief: Alligator Bioscience Gets Patent In United States
March 10 (Reuters) - Alligator Bioscience AB ATORX.ST: UNITED STATES PATENT AND TRADEMARK OFFICE GRANTS PATENT COVERING ALLIGATOR BIOSCIENCE'S BISPECIFIC ANTIBODY FORMAT PATENT PROVIDES PROTECTION FOR TETRAVALENT BISPECIFIC ANTIBODIES WITH DUAL ANTIGEN BINDING Source text: ID:nMFN5KglHF Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue